Acta Med. 2007, 50: 109-111

https://doi.org/10.14712/18059694.2017.65

A Pilot Study of Matrix Metalloproteinases on the Model of Daunorubicin-induced Cardiomyopathy in Rabbits

Anna Potáčováa, Michaela Adamcováa, Martin Štěrbab, Olga Popelováb, Tomáš Šimůnekc, Yvona Mazurovád, Ivana Gunčovád, Vladimír Geršlb

aCharles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Department of Physiology, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Department of Pharmacology, Hradec Králové, Czech Republic
cCharles University in Prague, Faculty of Pharmacy in Hradec Králové, Department of Biochemical Sciences, Hradec Králové, Czech Republic
dCharles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, Department of Histology and Embryology, Hradec Králové, Czech Republic

Received April 1, 2007
Accepted June 1, 2007

Matrix metalloproteinases (MMPs), activated by oxidative stress, play a key role during cardiac remodeling. In the present study we aimed to assess the role of MMPs in experimental cardiomyopathy induced by repeated 10-week administration of daunorubicin (3 mg/kg i.v.) to rabbits. In the daunorubicin group, the plasma cardiac troponin T levels (cTnT – a marker of myocardial necrosis) were significantly increased (p<0.05), commencing with the 8th administration compared with the controls. The amount of collagen (an estimate of fibrosis) was also significantly higher in the daunorubicin group (13.39 ± 0.97 mg/g wet weight) compared to the control group (10.03 ± 0.65 mg/g wet weight). In both groups, the LV MMP-activity was observed only in the gelatine substrate in the 70 kDa region (MMP-2), while no MMPs activities were detectable either in the casein or collagen containing zymograms. At the end of the experiment, the MMP- 2 activity was slightly up-regulated (by 16 %) compared with the controls.

Funding

This study was supported by the Charles University Grant Agency No. 7531/2007 C.

References

7 live references